Lantern Pharma Launches ZetaNomics AI Platform to Transform Cancer Research
Lantern Pharma (NASDAQ: LTRN) has launched ZetaNomics, an autonomous AI-powered computational biology platform designed to bring expert-level bioinformatics, biostatistics, and scientific reasoning to cancer research. The platform helps researchers design experiments, identify potential analytical pitfalls, and make statistically rigorous decisions across both rare and common cancers.
Powered by access to more than 615,000 curated cancer samples from 11 integrated data sources, ZetaNomics automatically organizes fragmented biomedical datasets and transforms natural language questions into analysis-ready research cohorts. According to the company, the platform can reduce weeks of manual data preparation into minutes, accelerating oncology research and drug discovery.
#LanternPharma
#LTRN
#ZetaNomics
#ArtificialIntelligence
#AI
#CancerResearch
#Bioinformatics
#Biostatistics
#DrugDiscovery
#PrecisionMedicine
#Oncology
#HealthcareInnovation
#NASDAQ
#JaneKing
#NewsOut
